Board Meeting23 Jul 2026, 01:25 pm
Solara Active Pharma Sciences Board Approves Q1 FY27 Unaudited Results
AI Summary
Solara Active Pharma Sciences Limited announced that its Board of Directors met on July 23, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The results, along with the limited review report from Deloitte Haskins & Sells, have been submitted to the exchange. The financial information will also be available on the company's investor relations website. The meeting commenced at 12:00 PM and concluded at 1:05 PM.
Key Highlights
- Board meeting held on July 23, 2026.
- Unaudited standalone and consolidated results approved.
- Financial results for the quarter ended June 30, 2026.
- Limited review report from Deloitte Haskins & Sells enclosed.
- Results to be available on the company website.
Price Impact
More from SOLARA